切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2017, Vol. 06 ›› Issue (06) : 267 -271. doi: 10.3877/cma.j.issn.2095-3216.2017.06.005

所属专题: 文献

专家论坛

急性肾脏病的治疗与预防
郭志勇1,(), 边琪1   
  1. 1. 200433 上海,海军军医大学附属长海医院
  • 收稿日期:2017-09-29 出版日期:2017-12-28
  • 通信作者: 郭志勇

Treatment and prevention of acute kidney disease

Zhiyong Guo1,(), Qi Bian1   

  1. 1. Changhai Hospital Affiliated to Naval Military Medical University, Shanghai 200433, China
  • Received:2017-09-29 Published:2017-12-28
  • Corresponding author: Zhiyong Guo
  • About author:
    Corresponding author: Guo Zhiyong, Email:
引用本文:

郭志勇, 边琪. 急性肾脏病的治疗与预防[J/OL]. 中华肾病研究电子杂志, 2017, 06(06): 267-271.

Zhiyong Guo, Qi Bian. Treatment and prevention of acute kidney disease[J/OL]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2017, 06(06): 267-271.

急性肾脏病(AKD)是指急性肾损伤发作后,急性或亚急性损伤和(或)肾功能降低持续7~90 d。是患者发生AKI之后重要的一段转归期,这一时期的处理对于AKI的最终转归至关重要。结合近期ADQI工作组提出对AKD的定义、分期和防治策略提出的共识,本文总结了目前对AKD防治的临床实践方案。积极筛查易感因素、识别高危人群、避免使用肾毒性药物、保持足够的肾脏灌注和维持内环境稳定等均是有效的预防措施;并重点阐述了AKD的随访要求、药物调整策略、肾脏替代治疗、原发病诊治等防治手段。通过增加对AKD的认识,积极采取干预措施促进持续进展性AKI的恢复,减少CKD的发生和进展。

Acute kidney disease (AKD) describes acute or subacute renal damage and/or loss of kidney function between 7 and 90 days after AKI initiation. It is an important period of transition after AKI. The treatment of this period is essential for the eventual prognosis of AKI. Recently, ADQI working group provided consensus on the definition, stages, and treatment and prevention strategy of AKD. This article summarized the current clinical practice strategy for AKD. The effective preventive measures for AKD includes actively screening susceptible factors, identifying high-risk groups, avoiding use of nephrotoxic drugs, keeping enough renal perfusion, and maintaining the stable internal environment. The other measures for AKD were also emphasized, including follow-up requirements, drug adjustment strategy, renal replacement therapy, and treatment for primary diseases. Increasing awareness of AKD plus active intervention will promote the recovery of progressive AKI, and reduce the occurrence and progression of CKD.

图1 急性肾脏病病程与临床治疗策略调整[5]
表1 急性肾脏病时药物选择需要考虑的因素
表2 不同分期急性肾脏病患者用药调整的时机
1
Lewington AJ, Cerdá J, Mehta RL. Raising awareness of acute kidney injury: a global perspective of a silent killer [J]. Kidney Int, 2013, 84(3): 457-467.
2
Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis [J]. Kidney Int, 2012, 81(5): 442-448.
3
Coca SG, Yusuf B, Shlipak MG, et al. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis [J]. Am J Kidney Dis, 2009, 53(6): 961-973.
4
KDIGO Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury [J]. Kidney Int Suppl, 2012, 2: 1-138.
5
Chawla LS, Bellomo R, Bihorac A, et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup [J]. Nat Rev Nephrol, 2017, 13(4): 241-257.
6
Palevsky PM, Zhang JH, O′Connor TZ, et al. Intensity of renal support in critically ill patients with acute kidney injury [J]. N Engl J Med, 2008, 359(1): 7-20.
7
Hsu CY, Chertow GM, McCulloch CE, et al. Nonrecovery of kidney function and death after acute on chronic renal failure [J]. Clin J Am Soc Nephrol, 2009, 4(5): 891-898.
8
James MT, Ghali WA, Knudtson ML, et al. Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography [J]. Circulation, 2011, 123(4): 409-416.
9
Goldstein SL, Jaber BL, Faubel S, et al. AKI transition of care: a potential opportunity to detect and prevent CKD [J]. Clin J Am Soc Nephrol, 2013, 8(3): 476-483.
10
杨莉. 急性肾损伤发病与修复的机制[J/CD].中华肾病研究电子杂志,2013, 2(3): 120-124.
11
Harel Z, Wald R, Bargman JM, et al. Nephrologist follow-up improves all-cause mortality of severe acute kidney injury survivors [J]. Kidney Int, 2013, 83(5): 901-908.
12
Matheny ME, Peterson JF, Eden SK, et al. Laboratory test surveillance following acute kidney injury [J]. PLoS One, 2014, 9(8): e103746.
13
Hickson LJ, Chaudhary S, Williams AW, et al. Predictors of outpatient kidney function recovery among patients who initiate hemodialysis in the hospital [J]. Am J Kidney Dis, 2015, 65(4): 592-602.
14
Forni LG, Darmon M, Ostermann M, et al. Renal recovery after acute kidney injury [J]. Intensive Care Med, 2017, 43(6): 855-866.
15
Dennis JM, Witting PK. Protective role for antioxidants in acute kidney disease [J]. Nutrients, 2017, 9(7): E718.
16
Chu R, Li C, Wang S, et al. Assessment of KDIGO definitions in patients with histopathologic evidence of acute renal disease [J]. Clin J Am Soc Nephrol, 2014, 9(7): 1175-1182.
17
Khwaja A. KDIGO clinical practice guidelines for acute kidney injury [J]. Nephron Clin Pract, 2012, 120(4): c179-c184.
18
姜物华,丁小强. 老年急性肾损伤的防治特点[J]. 中国实用内科杂志,2014, 34(12): 1147-1150.
[1] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[2] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[3] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[4] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[5] 刘柏隆, 周祥福. 压力性尿失禁阶梯治疗的项目介绍[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 125-125.
[6] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[7] 嵇振岭, 陈杰, 唐健雄. 重视复杂腹壁疝手术并发症的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 601-606.
[8] 江志鹏, 钟克力, 陈双. 复杂腹壁疝手术后腹腔高压与腹腔间室综合征的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 612-615.
[9] 王学虎, 赵渝. 复杂腹壁疝手术中血管损伤并发症的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 616-619.
[10] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[11] 陈伟杰, 何小东. 胆囊癌免疫靶向治疗进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 763-768.
[12] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[13] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[14] 张平骥, 徐钰, 李天水, 庞文翼, 符师宁, 张梦圆. 重症患者镇静治疗现状及期望的调查研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 562-567.
[15] 王昌前, 林婷婷, 宁雨露, 王颖杰, 谭文勇. 光免疫治疗在肿瘤领域的临床应用新进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 575-583.
阅读次数
全文


摘要